Autres langues

31/07 EUROAPI : Rapport financier semestriel 2026
31/07 EUROAPI : Availability of 2026 Half-year results financial report
31/07 EUROAPI_Availability of 2026 Half-year results financial report
29/07 Euroapi S.A. Reports Earnings Results for the Half Year Ended June 30, 2026
29/07 First-Half 2026 results confirm commercial and operational resilience in a challenging market environment - Transformation progressing as planned, including the divestment of the Brindisi site
29/07 Huvepharma EOOD entered into Share Purchase Agreement to acquire EUROAPI Italy SRL from Euroapi S.A..
27/05 Combined General Meeting of May 27, 2026
13/05 Euroapi says no decision made on Brindisi site amid buyer discussions
13/05 EUROAPI statement regarding the Brindisi site
30/04 EUROAPI : Availibility of preparatory documents
30/04 EUROAPI : Liquidity contract May 2026
30/04 EUROAPI : Liquidity Contract
30/04 EUROAPI_Liquidity Contract
29/04 Availabilty of 2026 AGM preparatory documents
27/03 EUROAPI : Availability of the 2025 Universal Registration Document, including the Annual Financial Report
27/03 EUROAPI - Availability of the 2025 Universal Registration Document
03/03 EUROAPI : Full-Year 2025 results
03/03 Euroapi FY Ebitda EUR 9.9 mln
03/03 2025 results: Core EBITDA margin improved despite sales headwinds, driven by strong cost discipline
03/03 Euroapi S.A. Provides Earnings Guidance for the Fy 2026
03/03 Euroapi S.A. Reports Earnings Results for the Full Year Ended December 31, 2025
17/12 Morning Meeting: La geopolitica pesa sull'Europa, Wall Street guarda a Micron e all'inflazione
16/12 Euroapi cuts FY net sales outlook
16/12 Euroapi expects mid-single digit decrease in 2025 net sales
16/12 Market update
Aucun résultat pour cette recherche
🔇